Annual EBIT
-$25.15 M
+$646.00 K+2.50%
31 December 2023
Summary:
Enlivex Therapeutics annual earnings before interest & taxes is currently -$25.15 million, with the most recent change of +$646.00 thousand (+2.50%) on 31 December 2023. During the last 3 years, it has fallen by -$15.37 million (-157.04%). ENLV annual EBIT is now -10882.97% below its all-time high of -$229.00 thousand, reached on 31 December 2012.ENLV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.99 M
+$964.00 K+24.41%
30 June 2024
Summary:
Enlivex Therapeutics quarterly earnings before interest & taxes is currently -$2.99 million, with the most recent change of +$964.00 thousand (+24.41%) on 30 June 2024. Over the past year, it has increased by +$2.64 million (+46.94%). ENLV quarterly EBIT is now -193.37% below its all-time high of $3.20 million, reached on 31 December 2017.ENLV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$18.66 M
+$3.66 M+16.41%
30 June 2024
Summary:
Enlivex Therapeutics TTM earnings before interest & taxes is currently -$18.66 million, with the most recent change of +$3.66 million (+16.41%) on 30 June 2024. Over the past year, it has increased by +$8.25 million (+30.66%). ENLV TTM EBIT is now -3305.33% below its all-time high of $582.00 thousand, reached on 30 June 2018.ENLV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | +46.9% | +30.7% |
| 3 y3 years | -157.0% | +22.7% | -23.0% |
| 5 y5 years | -374.6% | -45.7% | -125.9% |
ENLV EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -157.0% | +2.5% | at high | +61.9% | -23.0% | +30.8% |
| 5 y | 5 years | -374.6% | +2.5% | -57.5% | +61.9% | -127.3% | +30.8% |
| alltime | all time | <-9999.0% | +2.5% | -193.4% | +61.9% | -3305.3% | +30.8% |
Enlivex Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.99 M(-24.4%) | -$18.66 M(-16.4%) |
| Mar 2024 | - | -$3.95 M(-35.2%) | -$22.32 M(-11.3%) |
| Dec 2023 | -$25.15 M(-2.5%) | -$6.09 M(+8.2%) | -$25.15 M(-6.5%) |
| Sept 2023 | - | -$5.63 M(-15.4%) | -$26.91 M(-0.2%) |
| June 2023 | - | -$6.65 M(-2.0%) | -$26.95 M(+3.0%) |
| Mar 2023 | - | -$6.78 M(-13.5%) | -$26.18 M(+1.5%) |
| Dec 2022 | -$25.80 M(+33.7%) | -$7.84 M(+38.2%) | -$25.80 M(+0.1%) |
| Sept 2022 | - | -$5.68 M(-3.3%) | -$25.77 M(+7.6%) |
| June 2022 | - | -$5.87 M(-8.3%) | -$23.95 M(+9.4%) |
| Mar 2022 | - | -$6.40 M(-18.0%) | -$21.89 M(+13.5%) |
| Dec 2021 | -$19.29 M(+97.1%) | -$7.81 M(+102.2%) | -$19.29 M(+27.1%) |
| Sept 2021 | - | -$3.86 M(+1.5%) | -$15.17 M(+14.4%) |
| June 2021 | - | -$3.81 M(+0.2%) | -$13.27 M(+13.5%) |
| Mar 2021 | - | -$3.80 M(+2.8%) | -$11.69 M(+19.5%) |
| Dec 2020 | -$9.79 M(+13.5%) | -$3.70 M(+88.7%) | -$9.79 M(+7.6%) |
| Sept 2020 | - | -$1.96 M(-12.3%) | -$9.09 M(-1.0%) |
| June 2020 | - | -$2.23 M(+17.8%) | -$9.18 M(+11.9%) |
| Mar 2020 | - | -$1.90 M(-36.9%) | -$8.21 M(-4.8%) |
| Dec 2019 | -$8.62 M(+62.7%) | -$3.00 M(+46.6%) | -$8.62 M(+4.4%) |
| Sept 2019 | - | -$2.05 M(+62.7%) | -$8.26 M(+13.0%) |
| June 2019 | - | -$1.26 M(-45.4%) | -$7.31 M(+11.1%) |
| Mar 2019 | - | -$2.31 M(-12.7%) | -$6.58 M(+24.6%) |
| Dec 2018 | -$5.30 M(+144.1%) | -$2.64 M(+140.1%) | -$5.28 M(-1045.1%) |
| Sept 2018 | - | -$1.10 M(+108.5%) | $559.00 K(-4.0%) |
| June 2018 | - | -$528.00 K(-47.7%) | $582.00 K(-207.6%) |
| Mar 2018 | - | -$1.01 M(-131.6%) | -$541.00 K(-75.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$2.17 M(-86.3%) | $3.20 M(-396.7%) | -$2.17 M(-74.3%) |
| Sept 2017 | - | -$1.08 M(-34.7%) | -$8.44 M(-29.3%) |
| June 2017 | - | -$1.65 M(-37.5%) | -$11.94 M(-14.8%) |
| Mar 2017 | - | -$2.64 M(-14.1%) | -$14.01 M(-11.7%) |
| Dec 2016 | -$15.87 M(+2.5%) | -$3.07 M(-32.9%) | -$15.87 M(-10.0%) |
| Sept 2016 | - | -$4.58 M(+23.0%) | -$17.63 M(+6.0%) |
| June 2016 | - | -$3.72 M(-17.1%) | -$16.63 M(-0.1%) |
| Mar 2016 | - | -$4.49 M(-7.1%) | -$16.65 M(+7.6%) |
| Dec 2015 | -$15.48 M(+118.6%) | -$4.83 M(+34.7%) | -$15.48 M(+11.8%) |
| Sept 2015 | - | -$3.59 M(-4.0%) | -$13.84 M(+11.8%) |
| June 2015 | - | -$3.74 M(+12.7%) | -$12.38 M(+26.9%) |
| Mar 2015 | - | -$3.32 M(+3.8%) | -$9.76 M(+37.8%) |
| Dec 2014 | -$7.08 M(+519.4%) | -$3.20 M(+50.1%) | -$7.08 M(+51.9%) |
| Sept 2014 | - | -$2.13 M(+91.5%) | -$4.66 M(+71.1%) |
| June 2014 | - | -$1.11 M(+73.5%) | -$2.72 M(+56.0%) |
| Mar 2014 | - | -$641.00 K(-17.7%) | -$1.75 M(+58.0%) |
| Dec 2013 | -$1.14 M(+399.1%) | -$779.00 K(+305.7%) | -$1.10 M(+239.0%) |
| Sept 2013 | - | -$192.00 K(+43.3%) | -$326.00 K(+143.3%) |
| June 2013 | - | -$134.00 K | -$134.00 K |
| Dec 2012 | -$229.00 K(-72.6%) | - | - |
| Dec 2002 | -$836.20 K(-48.8%) | - | - |
| Dec 2001 | -$1.63 M(+26.0%) | - | - |
| Dec 2000 | -$1.30 M(+92.6%) | - | - |
| Dec 1999 | -$673.50 K(-56.9%) | - | - |
| Dec 1998 | -$1.56 M(-27.6%) | - | - |
| Dec 1997 | -$2.16 M | - | - |
FAQ
- What is Enlivex Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual EBIT year-on-year change?
- What is Enlivex Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly EBIT year-on-year change?
- What is Enlivex Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enlivex Therapeutics?
- What is Enlivex Therapeutics TTM EBIT year-on-year change?
What is Enlivex Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ENLV is -$25.15 M
What is the all time high annual EBIT for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual earnings before interest & taxes is -$229.00 K
What is Enlivex Therapeutics annual EBIT year-on-year change?
Over the past year, ENLV annual earnings before interest & taxes has changed by +$646.00 K (+2.50%)
What is Enlivex Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ENLV is -$2.99 M
What is the all time high quarterly EBIT for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly earnings before interest & taxes is $3.20 M
What is Enlivex Therapeutics quarterly EBIT year-on-year change?
Over the past year, ENLV quarterly earnings before interest & taxes has changed by +$2.64 M (+46.94%)
What is Enlivex Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ENLV is -$18.66 M
What is the all time high TTM EBIT for Enlivex Therapeutics?
Enlivex Therapeutics all-time high TTM earnings before interest & taxes is $582.00 K
What is Enlivex Therapeutics TTM EBIT year-on-year change?
Over the past year, ENLV TTM earnings before interest & taxes has changed by +$8.25 M (+30.66%)